Keywords: gsk, update, warnings, dexedrine, response, fda, call

GSK's update warnings on Dexedrine in response to FDA call

Article | 04 September 2006

Print This

In a letter posted on the US Food and Drug Administration's web site, UK drug major GlaxoSmithKline has provided notification ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in